Related Experiment Video
Updated: Jul 1, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Potential Inflammatory Mediators in Pericardial Fluids of Patients With Coronary Artery Diseases and Their
Reşat Dikme1, Mehmet Salih Aydın2, Ebru Temiz3
1Department of Perfusion Techniques Program, Vocational School of Health Services, Harran University, Şanlıurfa, Turkey.
Insights
Interleukin-33 (IL-33), fetuin A, and cytokeratin 18 (CK-18) protein levels are higher in pericardial fluid than plasma in coronary artery disease (CAD) patients. These findings suggest potential biomarkers for CAD diagnosis and treatment.
Area of Science:
- Cardiovascular Medicine
- Biochemistry
- Molecular Biology
Background:
- Coronary artery disease (CAD) is a leading cause of mortality worldwide.
- Identifying reliable biomarkers for CAD diagnosis and prognosis is crucial for effective patient management.
- Pericardial fluid (PF) offers a unique microenvironment close to the heart, potentially reflecting cardiac pathophysiology.
Purpose of the Study:
- To investigate the gene expression and protein levels of interleukin-33 (IL-33), fetuin A, and cytokeratin 18 (CK-18) in pericardial fluid (PF) and plasma of patients with CAD.
- To assess the potential of these molecules as biomarkers for CAD.
Main Methods:
- Protein levels of IL-33, fetuin A, and CK-18 in PF and plasma were quantified using ELISA.
- Gene expression levels of IL-33 and fetuin A were analyzed via quantitative reverse transcription-PCR (qRT-PCR).
- Correlations between protein levels and CAD patient characteristics were examined.
Main Results:
- Significantly higher protein levels of IL-33 and fetuin A were found in PF compared to plasma.
- Gene expression of IL-33 and fetuin A was higher in plasma than in PF.
- CK-18 protein levels were comparable between PF and plasma, but showed positive correlations with IL-33 and fetuin A in PF.
Conclusions:
- IL-33, fetuin A, and CK-18 in pericardial fluid show promise as potential biomarkers for coronary artery disease.
- Pericardial fluid, despite invasive collection, provides valuable insights into cardiac pathophysiology.
- These findings support the diagnostic and therapeutic potential of PF biomarkers in CAD management.
Abstract:
The aim of this study was to determine the gene expression and protein levels of interleukin-33 (IL-33), fetuin A and cytokeratin 18 (CK-18) in the pericardial fluid (PF) and plasma of patients with coronary artery disease (CAD) undergoing coronary artery bypass grafting (CABG). The CAD patients (mean age: 73.4 years) were enrolled. The IL-33, fetuin A, and CK-18 protein levels in pericardial fluid (PF) and plasma of patients with CAD were measured by ELISA, while IL-33 and Fetuin A gene expressions were analysed via quantitative reverse transcription-PCR (qRT-PCR). The IL-33 protein level in PF was significantly higher than plasma (PF: 57.09 ng/L; Plasma: 50.15 ng/L; p < 0.05). Similarly, the fetuin A protein levels were significantly elevated in PF compared to plasma (PF: 1060.53 mg/L; Plasma: 725.85 mg/L; p < 0.05). However, gene expression levels (ΔCt values) for IL-33 and fetuin A were significantly higher in plasma than in PF (p < 0.05). The CK-18 protein levels were comparable between plasma and PF (p > 0.05). Strong positive correlations were observed between CK-18 and IL-33 (r = 0.127, p < 0.001) and between CK-18 and fetuin A (r = 0.096, p < 0.001) in PF. The IL-33, fetuin A, and CK-18 levels in PF are predicted to have the potential to be used as a source of biomarkers for CAD. Although the collection of PF samples requires an invasive procedure, the proximity of PF to the heart tissue makes it a valuable source for understanding cardiac pathophysiology. These findings highlight the potential diagnostic and therapeutic utility of PF biomarkers in patients with CAD.
Related Concept Videos
Pericarditis I: Introduction
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Pericarditis II: Clinical Features and Diagnostic Tests
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Myocarditis I: Introduction
Pericarditis III: Medical Management